Actuate Therapeutics, Inc Common stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,620 | -4,548 | -5,402 | -5,944 |
EBIT | -5,968 | |||
Net Income | -5,625 | -4,553 | -5,407 | -5,949 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,017 | -3,736 | -6,677 | -4,348 |
Cash | 8,134 | 13,159 | 16,924 | 6,492 |
Basic Shares | 23,537 | 23,245 | 21,394 | 19,646 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -22,207 | -25,160 | -24,428 | -20,079 |
EBIT | -27,304 | -24,700 | -20,143 | |
Net Income | -22,227 | -27,285 | -24,744 | -20,159 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,206 | -21,842 | -21,625 | -17,794 |
Cash | 13,159 | 8,641 | 2,958 | 20,449 |
Basic Shares | 21,021 | 19,514 | 15,033 | 15,033 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.24 |
2025-12-31 | -$0.18 |
2025-09-30 | -$0.25 |
2025-06-30 | -$0.30 |